← Back to Clinical Trials
Recruiting NCT07294716

NCT07294716 Improving Visual Quality in Patients With Irregular Corneas Using Asymmetrical Toric Intraocular Lenses

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07294716
Status Recruiting
Phase
Sponsor Johannes Kepler University of Linz
Condition Irregular Astigmatism
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2026-01-20
Primary Completion 2027-01

Trial Parameters

Condition Irregular Astigmatism
Sponsor Johannes Kepler University of Linz
Study Type INTERVENTIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2026-01-20
Completion 2027-01
Interventions
AMILens Individual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Cataract surgery in patients with irregular corneas presents unique challenges, primarily due to the high variability in keratometry and corneal tomography measurements, which complicates accurate intraocular lens (IOL) calculations. In these patients, therapeutic options are currently limited to either non-toric IOLs and rigid contact lenses postoperatively or conventional toric IOLs for the reduction of total astigmatism within cataract surgery. While conventional toric IOLs may be beneficial in selected cases with a stable astigmatic pattern and clear axis, their effectiveness is largely limited, as significant irregularity and higher order aberrations reduce predictability, accuracy of formulae, and refractive outcomes. Therefore, the development of a reliable method to reduce total astigmatism - including irregular components - would represent a major advancement, potentially improving both visual function and patient quality of life. The aim of this exploratory study is to evaluate the effectiveness of customized toric intraocular lenses (AMILens Individual, AMIPLANT GmbH, Germany) in reducing total corneal astigmatism in patients with a significant irregular astigmatic component. These lenses are designed to address corneal aberrations up to the 6th Zernike order, thereby extending correction beyond the capabilities of conventional toric IOLs. To our knowledge, no clinical study has yet investigated this novel approach.

Eligibility Criteria

Inclusion Criteria: * Age 21 years or older * Scheduled cataract surgery * At least 1.75 D of total astigmatism in the CASIA2 measurement * At least 0.75 D of asymmetry or higher order irregularity within the 6mm zone of the real (total) index corneal refractive map of the CASIA2 measurements Exclusion Criteria: * Relevant central corneal scars * PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag * Combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery) * Postoperative best corrected distance visual acuity below 0.3 Snellen decimal * Pregnancy

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology